Molecular Diagnostics in Diabetes: From Biomarkers to Clinical Applications
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cell Biology and Pathology".
Deadline for manuscript submissions: 28 February 2026
Special Issue Editors
Interests: complementary and alternative medicine; osteoporosis; physiological markers and diagnostics; exercises; sport physiology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Diabetes is one of the most widespread growing chronic diseases worldwide, and left untreated, it is associated with significant complications and healthcare costs. Recent advances in molecular diagnostics have created new possibilities for the early detection and personalized management of diabetes and its complications. A better understanding of circulating molecular biomarkers, including cell-free DNA (cfDNA), microRNAs, and other molecular indicators, offers promising minimally invasive disease monitoring and treatment approaches. In this Special Issue, we aim to share the latest findings in diagnostic and therapeutic biomarkers in diabetes, and to explore their translational potential in clinical practice. We invite researchers and clinicians to submit original articles, reviews, and meta-analyses on new molecular diagnostic methods and their practical use in diabetes diagnosis and treatment. Join us in advancing diabetes care through innovative molecular diagnostics.
Dr. Robert Stawski
Dr. Konrad Walczak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- diabetes
- molecular diagnostics
- cell-free DNA (cfDNA)
- microRNAs
- circulating biomarkers
- diabetes complications
- personalized therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
